Literature DB >> 3852684

Blood cells as markers for metabolic disorders.

E Beutler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3852684     DOI: 10.1007/bf00320722

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


× No keyword cloud information.
  42 in total

1.  PHOSPHOFRUCTOKINASE DEFICIENCY IN SKELETAL MUSCLE. A NEW TYPE OF GLYCOGENOSIS.

Authors:  S TARUI; G OKUNO; Y IKURA; T TANAKA; M SUDA; M NISHIKAWA
Journal:  Biochem Biophys Res Commun       Date:  1965-05-03       Impact factor: 3.575

2.  Galactosemia screening of newborns in Massachusetts.

Authors:  V E Shih; H I Levy; V Karolkewicz; S Houghton; M L Efron; K J Isselbacher; E Beutler; R A MacCready
Journal:  N Engl J Med       Date:  1971-04-08       Impact factor: 91.245

3.  Erythrocyte and leukocyte phosphoglycerate kinase deficiency with neurologic disease.

Authors:  P N Konrad; D J McCarthy; A M Mauer; W N Valentine; D E Paglia
Journal:  J Pediatr       Date:  1973-03       Impact factor: 4.406

4.  Studies on leukocyte bracher enzyme activity in a family with type IV glycogenosis.

Authors:  C P Legum; H M Nitowsky
Journal:  J Pediatr       Date:  1969-01       Impact factor: 4.406

5.  Decreased red cell uroporphyrinogen I synthetase activity in intermittent acute porphyria.

Authors:  L J Strand; U A Meyer; B F Felsher; A G Redeker; H S Marver
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

6.  Vitamin B6 metabolism in human red cells. I. Variations in normal subjects.

Authors:  L R Solomon; R S Hillman
Journal:  Enzyme       Date:  1978

7.  Immunoreactive uroporphyrinogen decarboxylase in porphyria cutanea tarda.

Authors:  G H Elder; D M Sheppard; J A Tovey; A J Urquhart
Journal:  Lancet       Date:  1983-06-11       Impact factor: 79.321

8.  Glutathione reductase: stimulation in normal subjects by riboflavin supplementation.

Authors:  E Beutler
Journal:  Science       Date:  1969-08-08       Impact factor: 47.728

9.  Glucose and glycogen metabolism in erythrocytes from normal and glycogen storage disease type III subjects.

Authors:  S W Moses; R Chayoth; S Levin; E Lazarovitz; D Rubinstein
Journal:  J Clin Invest       Date:  1968-06       Impact factor: 14.808

10.  Fabry's disease: alpha-galactosidase deficiency.

Authors:  J A Kint
Journal:  Science       Date:  1970-02-27       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.